208 related articles for article (PubMed ID: 33453578)
1. A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy.
Li X; Fu W; Guo G; Liu M; Du W; Zhao J; Liu Y; Wang L; Dong J; Zhao X
Stem Cell Res; 2021 Mar; 51():102158. PubMed ID: 33453578
[TBL] [Abstract][Full Text] [Related]
2. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7.
Li X; Liu Y; Liu F; Wang X; Liu M; Du W; Zhao J; Wang M; Hu L; Wang C; Fu W; Dong J; Zhao X
Stem Cell Res; 2020 Mar; 43():101699. PubMed ID: 31931472
[TBL] [Abstract][Full Text] [Related]
3. Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations.
Cao X; Jahng JWS; Lee C; Zha Y; Wheeler MT; Sallam K; Wu JC
Stem Cell Res; 2021 Aug; 55():102455. PubMed ID: 34352619
[TBL] [Abstract][Full Text] [Related]
4. Generation of an iPSC line (ZZUNEUi016-A) derived from a hypertrophic cardiomyopathy patient with the heterozygote mutation in MYH7 gene.
Guo G; Fu W; Li X; Dong J; Zhao X; Zhang Y
Stem Cell Res; 2021 May; 53():102262. PubMed ID: 33636496
[TBL] [Abstract][Full Text] [Related]
5. Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7.
Dementyeva EV; Kovalenko VR; Zhiven MK; Ustyantseva EI; Kretov EI; Vyatkin YV; Zakian SM
Stem Cell Res; 2020 Jul; 46():101840. PubMed ID: 32422568
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.
Zhou J; Sun Y; Wang H; Wang H; Guo F; Chen X; Gong T; Jiang C; Liang P
Stem Cell Res; 2022 Oct; 64():102883. PubMed ID: 35944310
[TBL] [Abstract][Full Text] [Related]
7. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
8. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
9. Generation of two iPSC clones (MHHi021-A and MHHi021-B) from a patient with hypertrophic cardiomyopathy with p.Arg723Gly mutation in the MYH7 gene.
Merkert S; Wunderlich S; Beier J; Franke A; Schwanke K; Göhring G; Kraft T; Francino A; Zweigerdt R; Martin U
Stem Cell Res; 2021 Apr; 52():102208. PubMed ID: 33578365
[TBL] [Abstract][Full Text] [Related]
10. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control.
Fontaine V; Duboscq-Bidot L; Jouve C; Hamlin M; Curjol A; Briand V; Janiak P; Hulot JS; Pruniaux-Harnist MP; Charron P; Villard E
Stem Cell Res; 2021 Apr; 52():102245. PubMed ID: 33610018
[TBL] [Abstract][Full Text] [Related]
11. A heterozygous MYBPC3 (c. 772+1G > A) mutant human induced pluripotent stem cell line (ZZUNEUi025-A) generated from a male patient with hypertrophic cardiomyopathy.
Zhao X; Cao J; Li X; Liu M; Liu Y; Dong J; Zhao X
Stem Cell Res; 2022 Apr; 60():102722. PubMed ID: 35257994
[TBL] [Abstract][Full Text] [Related]
12. Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy.
Liu L; Shenoy SP; Jahng JWS; Liu Y; Knowles JW; Zhuge Y; Wu JC
Stem Cell Res; 2021 May; 53():102279. PubMed ID: 33743363
[TBL] [Abstract][Full Text] [Related]
13. Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln.
Holliday M; Ross SB; Lim S; Mangala M; Hill A; Szappanos HC; Hool L; Semsarian C
Stem Cell Res; 2018 Dec; 33():269-273. PubMed ID: 30508693
[TBL] [Abstract][Full Text] [Related]
14. Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients.
Wu H; Yang H; Rhee JW; Zhang JZ; Lam CK; Sallam K; Chang ACY; Ma N; Lee J; Zhang H; Blau HM; Bers DM; Wu JC
Eur Heart J; 2019 Dec; 40(45):3685-3695. PubMed ID: 31219556
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic MYH7 expression regulation contributes to tissue level allelic imbalance in hypertrophic cardiomyopathy.
Montag J; Syring M; Rose J; Weber AL; Ernstberger P; Mayer AK; Becker E; Keyser B; Dos Remedios C; Perrot A; van der Velden J; Francino A; Navarro-Lopez F; Ho CY; Brenner B; Kraft T
J Muscle Res Cell Motil; 2017 Aug; 38(3-4):291-302. PubMed ID: 29101517
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of
Loiben AM; Chien WM; Friedman CE; Chao LS; Weber G; Goldstein A; Sniadecki NJ; Murry CE; Yang KC
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902340
[TBL] [Abstract][Full Text] [Related]
17. Screening of MYH7 gene mutation sites in hypertrophic cardiomyopathy and its significance.
Liu HT; Ji FF; Wei L; Zuo AJ; Gao YX; Qi L; Jin B; Wang JG; Zhao P
Chin Med J (Engl); 2019 Dec; 132(23):2835-2841. PubMed ID: 31856055
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.
Ramachandra CJA; Kp MMJ; Chua J; Hernandez-Resendiz S; Liehn EA; Knöll R; Gan LM; Michaëlsson E; Jonsson MKB; Ryden-Markinhuhta K; Bhat RV; Fritsche-Danielson R; Lin YH; Sadayappan S; Tang HC; Wong P; Shim W; Hausenloy DJ
Cardiovasc Res; 2022 Jan; 118(2):517-530. PubMed ID: 33705529
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
